Showing results (1781-1790 of 5,064) with videos related to

Sort By:
Pageof 507
Multiple Sclerosis and Related Disorders|September 29, 2022
Improvement in the multiple sclerosis functional composite score by multi-function swing suspension training programSara Sepehri Far, Banafsheh Amiri, Mansour Sahebozamani, et al.
Multiple Sclerosis and Related Disorders|September 20, 2022
Relationship of coping strategies with mood symptoms, disease related characteristics and demographic variables in patients with multiple sclerosis: A systematic review studyBahman Bahmani, Shafigh Mehraban, Edgar Carnero Contentti, et al.
Multiple Sclerosis and Related Disorders|September 20, 2022
Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?Shane Arsenault, Rochelle Y Benoit, Fraser Clift, et al.
Multiple Sclerosis and Related Disorders|October 3, 2022
Exploring the impact of the COVID-19 pandemic on social isolation and mental health in people with MSShu Ling, Brandon Moss, Zhini Wang, et al.
Multiple Sclerosis and Related Disorders|September 18, 2022
Psychological flexibility, distress, and quality of life in secondary progressive multiple sclerosis: A cross-sectional studyChristopher Meek, Roshan das Nair, Nikos Evangelou, et al.
Multiple Sclerosis and Related Disorders|October 7, 2022
Visit-to-visit systolic blood pressure variability is associated with increased fatigue symptoms in multiple sclerosis patientsMyla D Goldman, Jennifer M Lobo, Seulgi Min, et al.
Multiple Sclerosis and Related Disorders|August 25, 2022
Efficacy, safety and patient reported outcomes in patients with active relapsing multiple sclerosis treated with ocrelizumab: Final results from the PRO-MSACTIVE studyEric Manchon, David Laplaud, Sandra Vukusic, et al.
Multiple Sclerosis and Related Disorders|January 14, 2022
Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, CanadaJacqueline M Solomon, Ashley Jones, Marika Hohol, et al.
Multiple Sclerosis and Related Disorders|January 14, 2022
Demand with low supply: A pipeline for personalized integrative medicine in multiple sclerosisHeena R Manglani, Brian C Healy, Ana-Maria Vranceanu
Multiple Sclerosis and Related Disorders|January 14, 2022
Drug library screen identifies inhibitors of toxic astrogliosisRuturaj Masvekar, Peter Kosa, Christopher Barbour, et al.
Pageof 507